GGI
KYTX icon

GordonMD Global Investments’s Kyverna Therapeutics KYTX Stock Holding History

GordonMD Global Investments’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$37.8M Hold
4,244,818
– – 18.3% 1
2026
Q1 		$36.6M Sell
4,244,818
-147,000
-3% -$1.22M 25.51% 1
2025
Q4 		$41.3M Buy
+4,391,818
New +$32.6M 29.6% 1

Other funds holding KYTX

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GordonMD Global Investments's KYTX Position: Q2 2026 in Review

GordonMD Global Investments held its Kyverna Therapeutics (KYTX) position steady in Q2 2026 at 4,244,818 shares worth $37.8M. The position accounts for 18.3% of the portfolio, ranked #1.

GordonMD Global Investments first reported a position in KYTX in Q4 2025 and has held it in 3 quarters since. The position peaked at $41.3M in Q4 2025. 121 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • GordonMD Global Investments held 4,244,818 shares of Kyverna Therapeutics worth $37.8M as of Q2 2026.
  • GordonMD Global Investments left its Kyverna Therapeutics share count unchanged in Q2 2026.
  • Kyverna Therapeutics made up 18.3% of GordonMD Global Investments's portfolio in Q2 2026, its #1 holding.
  • GordonMD Global Investments first reported a position in Kyverna Therapeutics in Q4 2025 and has held it in 3 quarters since.
  • GordonMD Global Investments's Kyverna Therapeutics position peaked at $41.3M in Q4 2025.
  • 121 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on GordonMD Global Investments's 13F filing for Q2 2026, filed 14 Aug 2026.